InvestorsHub Logo
Followers 2
Posts 514
Boards Moderated 0
Alias Born 06/15/2007

Re: None

Friday, 10/24/2014 3:22:50 PM

Friday, October 24, 2014 3:22:50 PM

Post# of 15819
RXII patent application
10/24/2014 09:24:58 AM ED


Alexandria, Oct. 24 -- RXI Pharmaceuticals has submitted a patent application for RNA interference in skin indications. Khvorova Anastasia, Salomon William, Kamens Joanne, Samarsky Dmitry, Woolf Tod M, Pavco Pamela A and Cardia James developed the invention.

The patent application number is 14/104450. International Patent Classification code is C12N 15/113 20060101 C12N015/113. Cooperative Patent Classification code is C12N 15/113 20130101.

U.S. Patent and Trademark Office has released the abstract. According to the abstract, "The present invention relates to RNAi constructs with improved tissue and cellular uptake characteristics and methods of use of these compounds in dermal applications."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPK News